Biolex Therapeutics developed therapeutic proteins and monoclonal antibodies that had been optimized to enhance their efficacy and potency.
Industries BiotechnologyHealth CareMedicalHeadquarters Regions Research Triangle, East Coast, Southern US Closed Date Aug 25, 2014 Founded Date 1997 Founders Anne-Marie Stomp Operating Status Closed Last Funding Type Debt Financing
Company Type For Profit
Contact Email info@biolex.com Phone Number 919.542.9901
Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a technology that genetically transforms the aquatic plant Lemna to enable the production of biologic
product candidates. Their main product aims at treating those afflicted with Hepatitis C.